All‐cause mortality · people with sickle cell disease
Reduction or prevention of kidney disease progression · people with sickle cell disease
1 finding from 1 review
Serious adverse events · people with sickle cell disease
Hydroxyurea showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Quality of life · people with sickle cell disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Frequency of blood transfusion · people with non‐transfusion‐dependent β‐thalassaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All major adverse effects · people with non‐transfusion‐dependent β‐thalassaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · people with non‐transfusion‐dependent β‐thalassaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean Hb F (g/dL) · people with non‐transfusion‐dependent β‐thalassaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain alterationa · people with sickle cell disease
1 finding from 1 review
Life‐threatening illness · people with sickle cell disease
1 finding from 1 review
Measures of HbF · people with sickle cell disease
1 finding from 1 review
Measures of ANC · people with sickle cell disease
1 finding from 1 review
Health status and quality of life · people with sickle cell disease
1 finding from 1 review
Adverse events or toxicity: differences in rates of specific adverse events · people with sickle cell disease
1 finding from 1 review